iloprost has been researched along with Ductus-Arteriosus--Patent* in 2 studies
2 other study(ies) available for iloprost and Ductus-Arteriosus--Patent
| Article | Year |
|---|---|
Transcatheter intervention following bosentan-iloprost treatment in a patient with patent ductus arteriosus and pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Ductus Arteriosus, Patent; Female; Humans; Hypertension, Pulmonary; Iloprost; Septal Occluder Device; Sulfonamides; Vasodilator Agents | 2012 |
Successful two-stage correction of ventricular septal defect and patent ductus arteriosus in a patient with fixed pulmonary hypertension.
We report a case of a 6-year-old boy with fixed severe pulmonary artery hypertension secondary to a ventricular septal defect (VSD) together with a patent ductus arteriosus (PDA). As a preliminary step, PDA embolization was performed following therapy with inhaled prostacyclin over a period of 6 months. Further, the patient underwent successful surgical VSD closure. We postulate that a staged procedure with long-term prostaglandin therapy might be capable of reducing pulmonary artery resistance and permitting total correction in a patient once considered to have inoperable pulmonary arteriopathy. Topics: Administration, Inhalation; Child; Combined Modality Therapy; Ductus Arteriosus, Patent; Embolization, Therapeutic; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Iloprost; Male; Septal Occluder Device; Vasodilator Agents | 2010 |